vs

Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $72.9M, roughly 1.0× CENTRAL PACIFIC FINANCIAL CORP). On growth, CENTRAL PACIFIC FINANCIAL CORP posted the faster year-over-year revenue change (6.0% vs -36.9%). Over the past eight quarters, CENTRAL PACIFIC FINANCIAL CORP's revenue compounded faster (6.7% CAGR vs -34.4%).

Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

CPF vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.0× larger
MED
$75.1M
$72.9M
CPF
Growing faster (revenue YoY)
CPF
CPF
+42.9% gap
CPF
6.0%
-36.9%
MED
Faster 2-yr revenue CAGR
CPF
CPF
Annualised
CPF
6.7%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CPF
CPF
MED
MED
Revenue
$72.9M
$75.1M
Net Profit
$20.7M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
28.4%
Revenue YoY
6.0%
-36.9%
Net Profit YoY
16.7%
EPS (diluted)
$0.78
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPF
CPF
MED
MED
Q1 26
$72.9M
Q4 25
$76.3M
$75.1M
Q3 25
$74.8M
$89.4M
Q2 25
$72.8M
$105.6M
Q1 25
$68.8M
$115.7M
Q4 24
$58.4M
$119.0M
Q3 24
$66.6M
$140.2M
Q2 24
$64.0M
$168.6M
Net Profit
CPF
CPF
MED
MED
Q1 26
$20.7M
Q4 25
$22.9M
Q3 25
$18.6M
$-2.3M
Q2 25
$18.3M
$2.5M
Q1 25
$17.8M
$-772.0K
Q4 24
$11.3M
Q3 24
$13.3M
$1.1M
Q2 24
$15.8M
$-8.2M
Gross Margin
CPF
CPF
MED
MED
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
CPF
CPF
MED
MED
Q1 26
Q4 25
37.0%
-10.4%
Q3 25
31.6%
-4.6%
Q2 25
32.8%
-1.0%
Q1 25
32.8%
-1.1%
Q4 24
23.0%
0.6%
Q3 24
25.6%
1.5%
Q2 24
32.2%
-4.7%
Net Margin
CPF
CPF
MED
MED
Q1 26
28.4%
Q4 25
30.0%
Q3 25
24.8%
-2.5%
Q2 25
25.1%
2.3%
Q1 25
25.8%
-0.7%
Q4 24
19.4%
Q3 24
20.0%
0.8%
Q2 24
24.7%
-4.8%
EPS (diluted)
CPF
CPF
MED
MED
Q1 26
$0.78
Q4 25
$0.85
$-1.64
Q3 25
$0.69
$-0.21
Q2 25
$0.67
$0.22
Q1 25
$0.65
$-0.07
Q4 24
$0.42
$0.08
Q3 24
$0.49
$0.10
Q2 24
$0.58
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPF
CPF
MED
MED
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
$76.5M
Stockholders' EquityBook value
$593.9M
$198.9M
Total Assets
$7.5B
$248.0M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPF
CPF
MED
MED
Q1 26
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Total Debt
CPF
CPF
MED
MED
Q1 26
$76.5M
Q4 25
$76.5M
Q3 25
$131.5M
Q2 25
$131.5M
Q1 25
$131.4M
Q4 24
$156.3M
Q3 24
$156.3M
Q2 24
$156.2M
Stockholders' Equity
CPF
CPF
MED
MED
Q1 26
$593.9M
Q4 25
$592.6M
$198.9M
Q3 25
$588.1M
$214.7M
Q2 25
$568.9M
$216.0M
Q1 25
$557.4M
$211.0M
Q4 24
$538.4M
$210.1M
Q3 24
$543.7M
$207.3M
Q2 24
$518.6M
$205.3M
Total Assets
CPF
CPF
MED
MED
Q1 26
$7.5B
Q4 25
$7.4B
$248.0M
Q3 25
$7.4B
$268.2M
Q2 25
$7.4B
$269.3M
Q1 25
$7.4B
$280.0M
Q4 24
$7.5B
$284.2M
Q3 24
$7.4B
$291.2M
Q2 24
$7.4B
$293.5M
Debt / Equity
CPF
CPF
MED
MED
Q1 26
0.13×
Q4 25
0.13×
Q3 25
0.22×
Q2 25
0.23×
Q1 25
0.24×
Q4 24
0.29×
Q3 24
0.29×
Q2 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPF
CPF
MED
MED
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPF
CPF
MED
MED
Q1 26
Q4 25
$97.5M
$-5.3M
Q3 25
$22.2M
$12.1M
Q2 25
$34.3M
$-3.4M
Q1 25
$20.4M
$3.4M
Q4 24
$90.5M
$-4.9M
Q3 24
$21.3M
$9.1M
Q2 24
$25.9M
$13.1M
Free Cash Flow
CPF
CPF
MED
MED
Q1 26
Q4 25
$92.3M
$-6.6M
Q3 25
$21.4M
$10.8M
Q2 25
$32.3M
$-4.8M
Q1 25
$19.6M
$1.9M
Q4 24
$75.4M
$-7.2M
Q3 24
$15.6M
$7.7M
Q2 24
$21.3M
$11.1M
FCF Margin
CPF
CPF
MED
MED
Q1 26
Q4 25
121.0%
-8.8%
Q3 25
28.6%
12.0%
Q2 25
44.3%
-4.5%
Q1 25
28.4%
1.6%
Q4 24
129.2%
-6.1%
Q3 24
23.5%
5.5%
Q2 24
33.2%
6.6%
Capex Intensity
CPF
CPF
MED
MED
Q1 26
Q4 25
6.8%
1.8%
Q3 25
1.2%
1.5%
Q2 25
2.7%
1.3%
Q1 25
1.3%
1.3%
Q4 24
25.8%
1.9%
Q3 24
8.5%
1.0%
Q2 24
7.3%
1.1%
Cash Conversion
CPF
CPF
MED
MED
Q1 26
Q4 25
4.26×
Q3 25
1.20×
Q2 25
1.88×
-1.36×
Q1 25
1.15×
Q4 24
7.98×
Q3 24
1.60×
8.04×
Q2 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons